(Press-News.org) Researchers have uncovered evidence hinting that the most common bug spray ingredient, DEET, might cause reproductive problems by affecting the formation of egg cells during pregnancy.
The findings come from a study in C. elegans — worms that don’t look like they have much in common with humans yet serve as surprisingly useful bellwethers of how toxins in the environment affect human reproduction.
Get more HMS news here
The research, published Jan. 4 in iScience, raises difficult questions. Chief among them is how to balance the possible reproductive harms of DEET-containing products in people — including infertility, miscarriage, or birth defects — with the need to ensure that people remain protected from diseases transmitted through insect bites, such as malaria, Lyme disease, West Nile virus, and Zika virus disease.
Whether and how much DEET use causes reproductive problems in humans will need to be confirmed in future studies. Such studies have been scarce to date in humans because of the ethical concerns involved.
Harvard Medicine News spoke with study senior author Monica Colaiácovo, professor of genetics in the Blavatnik Institute at Harvard Medical School, about what her team found and what it means.
Harvard Medicine News: Why did you conduct this study?
Monica Colaiácovo: The biggest motivator was how high DEET scored in our initial screens of how various chemicals in our environment affect meiosis, using the model organism C. elegans. Meiosis is the type of cell division that creates eggs and sperm. DEET was one of our top hits in terms of chromosomes not separating properly, so eggs end up with abnormal numbers of chromosomes. In humans, this can cause miscarriage, stillbirth, infertility, and genetic conditions such as Down syndrome. We knew we had to look at this carefully.
Monica Colaiácovo
Research has shown that DEET products can have neurologic effects on people who use them, but no one had really looked at what DEET is doing in meiosis. We wanted to understand whether it would cause a problem. Only a few human studies have been done, and practically everyone uses DEET, so the possibility that it could affect reproduction felt palpable for people in our lab.
HMNews: What did you find?
Colaiácovo: Using our worm model, we showed for the first time that DEET can have effects on meiosis. Then we showed why.
We saw that DEET has a significant impact on gene expression — the pattern of genes that are active or inactive in a cell. We found that the change resulted in oxidative stress (an imbalance between free radicals and antioxidants) and abnormal structure of the materials that form chromosomes, which compromised the ability of chromosomes to separate properly as the cell divided. Egg cells and the worm embryos they gave rise to were less healthy.
Left two images: Normal chromosome separation during meiosis in worms. Right three images: DEET exposure caused a variety of disruptions. Images: Nara Shin
HMNews: How applicable are the worm findings to humans?
Colaiácovo: That is always the big question. Many human genes have equivalents in C. elegans, and worms are a powerful model for looking at effects on reproduction. C. elegans have been instrumental in uncovering how environmental toxicants such as the plastics chemical BPA can harm reproductive health.
We observed the changes in meiosis when the levels of DEET inside the worms were the same as, and in some cases lower than, what you find in blood or urine samples from the regular human population. That said, the paradigm for exposure wasn’t the same as it is for most people. The worms were exposed to DEET for 24 hours at a time, which may not apply to anyone, or apply to only certain groups, such as agricultural workers. And there are some metabolic and physiological differences between worms and humans.
A very important thing from our studies is that we’re providing reproducible, well-controlled, substantial data. Other groups can take up this work in mice or other animal models and further advance our understanding of what DEET may be doing in human reproductive systems. We can also build on this evidence to flag chemicals of concern for policymakers.
DEET exposure led to missing, aggregated, and abnormal eggs in the worms. Images: Nara Shin
HMNews: At this stage, how would you frame recommendations for people? How do you balance reproductive health with prevention of diseases from mosquitoes and ticks?
Colaiácovo: My family is from South America, where Zika and dengue, for example, are common, and I want to make sure people are not scared away from being careful. So-called tropical diseases transmitted by insects are moving into new regions of the world as the climate changes, putting more and more people at risk. The consequences of stopping the use of insect repellents can be very serious.
RELATED STORY
What We Sow
So, we want prevention. We want repellents. And DEET is a very effective option we have right now. At this moment, I would say we should be aware of the potential reproductive risks of DEET-containing products and be sure to follow the application instructions when using them. Our work suggests this is very important for pregnant women because female meiosis begins in the developing fetus in the womb.
I would love to see research give rise to best practices for applying DEET products during pregnancy, when there’s often so much confusion and anxiety about what to do or not do.
I also hope our work helps drive the development of DEET alternatives that are safe and effective. It would be great to have an effective insect repellent that doesn’t make us worry about our health or that of our children.
Authorship, funding, disclosures
The work was led by co-first authors Nara Shin, a former postdoc in the Colaiácovo lab who is now at BostonGene, and Laura Lascarez-Lagunas, HMS annual research associate in genetics.
END
Worm study raises concern about DEET's effect on reproduction
Findings suggest need to consider reproductive health alongside prevention of insect-borne diseases
2024-01-04
ELSE PRESS RELEASES FROM THIS DATE:
Hearing loss, hearing aid use, and risk of dementia in older adults
2024-01-04
About The Study: The results of this study that included 573,000 persons suggest that hearing loss was associated with increased dementia risk, especially among people not using hearing aids, suggesting that hearing aids might prevent or delay the onset and progression of dementia. The risk estimates were lower than in previous studies, highlighting the need for more high-quality longitudinal studies.
Authors: Manuella Lech Cantuaria, Ph.D., of the University of Southern Denmark in Odense, is the corresponding author. (doi:10.1001/jamaoto.2023.3509)
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
Editor’s ...
Limited English proficiency and sepsis mortality by race and ethnicity
2024-01-04
About The Study: The findings of this study of 2,709 patients hospitalized with sepsis from 2016 to 2019 at an urban tertiary care center suggest a language-based inequity in outcomes. Further studies are needed to understand drivers of this inequity, how it may manifest in other diverse health systems, and to inform equitable care models for patients with limited English proficiency.
Authors: Neha P. Limaye, M.D., M.P.H., of Mount Sinai Hospital in New York, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link ...
Study reveals new genetic link between anorexia nervosa and being an early riser
2024-01-04
BOSTON – New research indicates that the eating disorder anorexia nervosa is associated with being an early riser, unlike many other disorders that tend to be evening-based such as depression, binge eating disorder and schizophrenia.
The study, which is published in JAMA Network Open and led by investigators at Massachusetts General Hospital (MGH), in collaboration with University College London and the University of the Republic in Uruguay, also revealed a link between anorexia nervosa and insomnia risk.
Previous research has suggested a possible connection between eating disorders and the body’s internal clock, or circadian clock, which controls a wide range of biological ...
Immune atlas at cell level points to new combination treatment for incurable childhood cancer
2024-01-04
Press release: Princess Máxima Center for pediatric oncology
EMBARGO: JANUARY 4, 2024 AT 11:00 AM ET (US)
A detailed 'atlas' of neuroblastoma tumors points to a new target for immunotherapy. Scientists from the Princess Máxima Center for pediatric oncology in the Netherlands mapped this childhood tumor at the level of individual cancer and immune cells. In doing so, they discovered a brake on the immune system that can be blocked with existing immunotherapy. The results in the lab are promising; preparations for a clinical study are underway.
Every year, 25 children in the Netherlands ...
The Colorado Center for Personalized Medicine highlighted as a leader in precision medicine in research and clinical care
2024-01-04
A new peer-reviewed study in the American Journal of Human Genetics highlights the work of the biobank at the Colorado Center for Personalized Medicine (CCPM), a world-class site for precision medicine in research and clinical care created in partnership with the University of Colorado Anschutz Medical Campus and UCHealth.
The paper focuses on CCPM’s research and personalized medical care.
“We’re one of the only institutions in the world that has accomplished the dual-purpose of using genetic information to accelerate scientific discovery in research while providing actionable clinical results to patients that ...
Treating tuberculosis when antibiotics no longer work
2024-01-04
In cooperation with research partners in Germany and France, the infectious disease specialist Dr Jan Rybniker and his team at University Hospital Cologne and the University of Cologne’s Faculty of Medicine have identified new, antibiotic molecules that target Mycobacterium tuberculosis and make it less pathogenic for humans. In addition, some of the discovered substances may allow for a renewed treatment of tuberculosis with available medications – including strains of the bacterium that have already developed drug resistance. The research has been published in the article ‘Discovery of dual-active ethionamide boosters ...
Supercharging CAR-T cells for cancer treatment
2024-01-04
At EPFL's School of Engineering, Professor Li Tang's Laboratory of Biomaterials for Immunoengineering has made significant strides in cancer treatment research. In laboratory settings, this innovative CAR-T therapy has consistently eradicated cancerous tumors in mouse models. Separately, in on-going clinical trials, eleven patients seemed to achieve complete remission using this treatment, marking a success rate of 100% to date. Notably, evidence from the lab study, published in Nature Biotechnology, suggests the therapy's long-term effectiveness, and indicates that its fabrication may be both quicker and more cost-effective ...
Minimizing immunotherapy’s potentially harmful side effects
2024-01-04
MIAMI, FLORIDA (EMBARGOED UNTIL JAN. 4, 2024, at 10 AM EST) – Recent advances in treating multiple myeloma, the second most common blood cancer, and other blood malignancies are providing improved outcomes – and hope – to patients worldwide.
But treatment breakthroughs such as the immunotherapy drug teclistamab can lead to potentially lethal side effects, including cytokine release syndrome (CRS) and immune cell-associated neurotoxicity syndrome (ICANS).
These potential side effects have necessitated giving immunotherapy drugs in the hospital setting, where patients remain for five to seven days and receive other drugs ...
Study finds paxlovid treatment does not reduce risk of long COVID
2024-01-04
A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection. They also found a higher proportion of individuals with acute symptoms rebound and test-positivity than previously reported.
The study appears Jan. 4, 2024, in the Journal of Medical Virology.
Paxlovid treatment for acute COVID-19 has been shown to be effective for high-risk unvaccinated individuals. But the effect of the treatment on long COVID risk, including whether it protects vaccinated people from getting long COVID, has been less clear.
The ...
Menarini Group and Insilico Medicine enter global exclusive license agreement for novel KAT6 inhibitor for potential breast cancer treatment and other oncology indications
2024-01-04
● KAT6 is an emerging target in hormone sensitive breast tumors and other cancers. Overexpression of KAT6A/B correlates with poor clinical outcomes in patients with ER+/HER2- breast cancer – the most common subtype.
● The molecule has demonstrated strong preclinical activity. Insilico Medicine presented data on the novel molecule at the San Antonio Breast Cancer Symposium in early December.
● This agreement includes upfront and milestone payments with a combined potential value of over $500m and sales royalties.
FLORENCE, Italy and NEW YORK: The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, ...
LAST 30 PRESS RELEASES:
HKU ecologists uncover significant ecological impact of hybrid grouper release through religious practices
New register opens to crown Champion Trees across the U.S.
A unified approach to health data exchange
New superconductor with hallmark of unconventional superconductivity discovered
Global HIV study finds that cardiovascular risk models underestimate for key populations
New study offers insights into how populations conform or go against the crowd
Development of a high-performance AI device utilizing ion-controlled spin wave interference in magnetic materials
WashU researchers map individual brain dynamics
Technology for oxidizing atmospheric methane won’t help the climate
US Department of Energy announces Early Career Research Program for FY 2025
PECASE winners: 3 UVA engineering professors receive presidential early career awards
‘Turn on the lights’: DAVD display helps navy divers navigate undersea conditions
MSU researcher’s breakthrough model sheds light on solar storms and space weather
Nebraska psychology professor recognized with Presidential Early Career Award
New data shows how ‘rage giving’ boosted immigrant-serving nonprofits during the first Trump Administration
Unique characteristics of a rare liver cancer identified as clinical trial of new treatment begins
From lab to field: CABBI pipeline delivers oil-rich sorghum
Stem cell therapy jumpstarts brain recovery after stroke
Polymer editing can upcycle waste into higher-performance plastics
Research on past hurricanes aims to reduce future risk
UT Health San Antonio, UTSA researchers receive prestigious 2025 Hill Prizes for medicine and technology
Panorama of our nearest galactic neighbor unveils hundreds of millions of stars
A chain reaction: HIV vaccines can lead to antibodies against antibodies
Bacteria in polymers form cables that grow into living gels
Rotavirus protein NSP4 manipulates gastrointestinal disease severity
‘Ding-dong:’ A study finds specific neurons with an immune doorbell
A major advance in biology combines DNA and RNA and could revolutionize cancer treatments
Neutrophil elastase as a predictor of delivery in pregnant women with preterm labor
NIH to lead implementation of National Plan to End Parkinson’s Act
Growth of private equity and hospital consolidation in primary care and price implications
[Press-News.org] Worm study raises concern about DEET's effect on reproductionFindings suggest need to consider reproductive health alongside prevention of insect-borne diseases